Amazon receives FDA warning letter for supplements with undeclared ingredients

Amazon has received an FDA warning for selling “supplements” on its marketplace that secretly contained prescription erectile dysfunction drugs like Viagra and Cialis, highlighting long‑standing safety and counterfeit problems in its third‑party ecosystem. Commenters argue this exposes broader regulatory gaps around dietary supplements, criticize Amazon’s commingled inventory and weak seller controls, and debate how much liability large platforms should bear compared to small manufacturers. Many say they now avoid buying anything ingestible or applied to the body from Amazon, favoring regulated supply chains, independent certification, or brick‑and‑mortar retailers instead.

Role and limits of the FDA / regulators

  • Many see this warning letter as an example of why the FDA is necessary: undeclared drug APIs in supplements can seriously harm or kill people, and consumers can’t realistically self‑protect.
  • Others argue the FDA is both underpowered (especially for supplements) and overbearing (slowing drug trials, keeping safe drugs Rx‑only, creating de facto bans).
  • Several note supplements are structurally under‑regulated in the US due to 1990s law; enforcement is sparse and often whistleblower-driven.
  • There’s debate over “whack‑a‑mole” (reactive product takedowns) vs. pushing large intermediaries to prevent risks up front.

Amazon’s responsibility and marketplace design

  • Strong sentiment that Amazon has turned into a “you’re on your own” marketplace: counterfeits, fake certifications, hijacked listings, and commingled inventory.
  • Commingling (mixing stock from different sellers under one SKU) is repeatedly flagged as a core problem: even “Sold by Amazon” items can be counterfeit or tainted.
  • Some argue Amazon should bear retailer‑like liability, including for damages from counterfeit or mislabeled goods; others say regulators should mainly target manufacturers/importers.
  • Suggestions: ban Amazon from supplements entirely; at minimum, end commingling, require domestic responsible entities, or force robust verification and lot testing.

Supplement industry and safety

  • Multiple commenters with industry experience describe the sector as “wild west”: tiny FDA teams, minimal follow‑up, many products spiked with prohibited substances or mislabeled ingredients.
  • Pointed out pattern: ED supplements and sports/“male energy” products are frequently found to contain hidden prescription drugs or steroids.
  • Others emphasize that simply having formal standards (COAs, GMP, labeling) is meaningless without real spot checks and enforcement.

User experiences and coping strategies

  • Many report receiving counterfeit or obviously altered consumables and cosmetics (shampoos, gels, vitamins, lotions) from Amazon; some describe burns, hair loss, or obviously wrong formulations.
  • Common personal rules: never buy anything ingestible or topical from Amazon; avoid easily faked items (SD cards, sheets, branded electronics); prefer direct-from-manufacturer, big-box stores, or vetted certifications (NSF, USP, etc.).
  • Some now treat Amazon mainly as a source for cheap, non‑critical “gizmos.”

ED drugs and Rx vs OTC debate

  • The specific violation (undeclared sildenafil/tadalafil in “natural” products) triggers a broader argument over whether these drugs should simply be OTC or pharmacist‑dispensed.
  • One side: good safety profile, already widely and informally available, gatekeeping mainly adds cost/embarrassment and drives people to sketchy supplements.
  • Other side: real interactions and contraindications (especially with heart meds); prescription barrier or pharmacist counseling is justified to manage those risks.